|
|
|
|
 |
CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008 |
| Companies mentioned in this article: |
|
BDO Seidman, LLP - CardioDynamics |
|
| 5/9/2008 @ 6:23 AM
print this article -
email to a friend -
join our eNewsletter
|
 |
CardioDynamics (NASDAQ:CDIC) , the innovator and leader of BioZ impedance cardiography (ICG) technology, today announced the reverse split of 1 for 7 shares of the Company's common stock was approved by its Shareholders at the Company's Annual Shareholders Meeting earlier today.
The record date for the reverse split has been designated as the close of business today, May 8, 2008. The Company's common stock will begin trading tomorrow, May 9, 2008, on The Nasdaq Capital Market on a split-adjusted basis. The Company's stock will trade under the symbol "CDICD" for a period of approximately twenty trading days following the implementation of the reverse split to denote the reverse split, after which time, the trading symbol will revert to "CDIC". In the reverse split, each seven shares of CardioDynamics common stock issued and outstanding will be combined into one share of common stock, which initially should have the effect of proportionately increasing the stock price. Following the reverse split, the total number of shares outstanding will be reduced to approximately 7.2 million shares. Additional information regarding the reverse stock split can be found in the Company's Current Report on Form 8-K to be filed with the Securities and Exchange Commission on May 9, 2008.
Michael K. Perry, CardioDynamics Chief Executive Officer, stated, "We appreciate the confidence in our Company the shareholders have shown through their overwhelming support of the reverse stock split, with 87% of the voted shares in favor of the proposal. The approval will help us maintain our Nasdaq listing, improves our capital structure and has the potential to attract a greater level of interest among investors and analysts. Additionally, the timing is complementary with our Company's five consecutive quarters of revenue growth, international sales momentum, continued growth plan for 2008, and intense focus on achieving positive operating cash flow by the fourth quarter of 2008. Collectively, we believe these factors are catalysts for growth in shareholder value."
The Company also reported that all other proposals presented at the Annual Meeting were approved including re-election of its Board of Directors and ratification of the appointment of BDO Seidman, LLP, as the Company's independent registered public accounting firm.
About CardioDynamics:
CardioDynamics (NASDAQ:CDIC) , the ICG Company, is the innovator and leader of an important medical technology called BioZ Impedance Cardiography (ICG). The Company develops, manufactures and markets noninvasive BioZ ICG products. The Company's BioZ ICG Systems are being used by physicians around the world to help battle the number one killer of men and women -- cardiovascular disease. Partners include GE Healthcare, Philips Medical Systems, and Mindray. For additional information, please refer to the company's Web site at www.cdic.com/. |
| BioTech / BioMedical / Medical |
|
|
| |
| Friday, May 16, 2008 |
 |
|
Phenomix Announces PHX1149 Phase 2b Clinical Trial Results for Type 2 Diabetes Posted 3:41 PM PST
ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study Posted 6:15 AM PST
Invitrogen Launches Cell Therapy Business Unit Posted 6:02 AM PST
|
| |
| Thursday, May 15, 2008 |
|
|
CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting Posted 8:57 AM PST
|
| |
| Wednesday, May 14, 2008 |
|
|
Ardea Biosciences Announces Upcoming Corporate Meetings Posted 5:32 PM PST
Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute Posted 9:25 AM PST
TorreyPines Therapeutics to Present at the JMP Seventh Annual Securities Conference Posted 9:22 AM PST
PacificGMP Completes GMP Product Fill for Trius Therapeutics Posted 9:18 AM PST
Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals Posted 9:17 AM PST
Outsource Manufacturing, Inc., San Diego Contract Manufacturer, Certified to ISO 13485 Posted 8:40 AM PST
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Posted 8:14 AM PST
International Stem Cell Corporation’s Human Parthenogenetic Stem Cells to be used in the Development of Treatments for Liver Disease Posted 8:13 AM PST
|
| |
| Tuesday, May 13, 2008 |
|
|
ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference Posted 9:37 AM PST
Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center Posted 9:35 AM PST
AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients Posted 9:32 AM PST
Transdel Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference Posted 9:30 AM PST
Lankford Selected to Build New $115 Million Research Facility for San Diego Consortium for Regenerative Medicine Posted 9:03 AM PST
Sequenom to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference Posted 8:54 AM PST
Invitrogen Launches New Animal Origin Free Substrate for Stem Cells Posted 8:52 AM PST
Bio-Matrix Scientific Group, Inc. to Issue Preferred Stock Dividend to Its Shareholders of Record May 28th Posted 8:42 AM PST
|
| |
| Monday, May 12, 2008 |
|
|
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference Posted 5:00 PM PST
Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences Posted 4:48 PM PST
Cytori to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference Rodman & Renshaw Global Healthcare Conference 2008 Posted 4:04 PM PST
Novalar Receives FDA Approval for OraVerse Posted 6:18 AM PST
Vical to Present at Upcoming Investor Conferences Posted 6:17 AM PST
Amylin Pharmaceuticals to Present at Baird Growth Stock Conference Posted 6:17 AM PST
Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial Posted 6:12 AM PST
Yale University Purchases Sequenom MassARRAY Platform Posted 6:06 AM PST
Hollis-Eden Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference Posted 6:04 AM PST
|
| |
| Friday, May 9, 2008 |
|
|
Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference Posted 6:24 AM PST
CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008 Posted 6:23 AM PST
Gen-Probe to Webcast Two Upcoming Investor Presentations Posted 6:21 AM PST
Cytori Reports First Celution System Revenues During the First Quarter; Provides Update on Celution System Commercialization Posted 6:15 AM PST
|
| |
| Thursday, May 8, 2008 |
|
|
Total Training Selected as the Exclusive In-the-Box Video Training Provider for Microsoft Expression Studio 2 Posted 3:38 PM PST
Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference Posted 3:36 PM PST
Metabasis to Present at the Bank of America 2008 Health Care Conference Posted 3:29 PM PST
Ortho Organizers Introduces New Premium Product Line - O2 Select Orthodontic Instruments Posted 8:36 AM PST
Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter Posted 8:35 AM PST
DR Systems’ Integration of Mammography with PACS to Be Showcased at ACR Meeting Posted 8:05 AM PST
Nvitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells Posted 8:05 AM PST
Bio-Matrix Scientific Group Identifies Near Term Revenue Sources Posted 8:02 AM PST
Aethlon Medical Releases Smallpox Related Research Data Posted 8:00 AM PST
|
| |
| Wednesday, May 7, 2008 |
|
|
Amylin Pharmaceuticals to Present at Bank of America Healthcare Conference Posted 2:18 PM PST
Sequenom Abstract Selected for ‘Blue Ribbon’ Designation for Presentation at ACOG Annual Meeting Posted 6:23 AM PST
Orexigen Therapeutics Announces Completion of Patient Enrollment in Phase III Clinical Program for Contrave Posted 6:23 AM PST
La Jolla Pharmaceutical Company Announces Pricing of Common Stock and Warrant Unit Offering Posted 6:21 AM PST
Invitrogen Scientists Link microRNA Sequences to Cancer Using RNA Samples from BioServe Posted 6:11 AM PST
Bio-Matrix Scientific Group, Inc. Installs Computype’s Secured Blood Bank Labeling and Identification Systems for its Adult Stem Cell Processing and Cryogenic Banking Laboratories Posted 6:09 AM PST
|
| |
| Tuesday, May 6, 2008 |
|
|
Illumina Completes Sequencing of African Trio Posted 8:59 AM PST
Aethlon Hemopurifier Effective in Capturing West Nile Virus Posted 8:59 AM PST
TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project Posted 8:24 AM PST
Halozyme Therapeutics to Present at Upcoming Investor Conferences Posted 8:18 AM PST
NuVasive to Present at Bank of America 2008 Health Care Conference Posted 8:08 AM PST
|
| |
| Monday, May 5, 2008 |
|
|
Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity Posted 4:29 PM PST
Biocept Launches Noninvasive Prenatal Rh(D) Diagnostic at Annual ACOG Scientific Meeting Posted 6:39 AM PST
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca Posted 6:37 AM PST
Orexigen Therapeutics to Present at Upcoming Investor Conferences Posted 6:32 AM PST
Bio-Matrix Scientific Group, Inc. Submits Application and Quality Systems Documentation to the State of California for Tissue Bank License Posted 6:31 AM PST
Applied Biosystems & Bio-Rad Gain Gene Expression Profiling Market Share Posted 6:02 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5.000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|
